Novartis Gains Four New Drugs Under Japan NHI Reimbursement; Astellas, Takeda, BMS, GSK Make Gains
This article was originally published in PharmAsia News
Executive Summary
TOKYO - At the recommendation of the Central Social Insurance Medical Council, known as Chuikyo in Japanese, the Ministry of Health, Labor and Welfare has listed 11 new composites for national health insurance reimbursement coverage